Establishing a cord blood banking and transplantation program in Mexico:: a single institution experience

被引:15
作者
Novelo-Garza, Barbara [1 ,2 ,3 ,4 ,5 ,6 ]
Limon-Flores, Alejandro [1 ,2 ,3 ,4 ,5 ,6 ]
Guerra-Marquez, Angel [1 ,2 ,3 ,4 ,5 ,6 ]
Luna-Bautista, Fernando [1 ,2 ,3 ,4 ,5 ,6 ]
Juan-Shum, Luis [1 ,2 ,3 ,4 ,5 ,6 ]
Montero, Ines [1 ,2 ,3 ,4 ,5 ,6 ]
Sanchez-Valle, Elizabeth [1 ,2 ,3 ,4 ,5 ,6 ]
Velez-Ruelas, Maria Antonieta [1 ,2 ,3 ,4 ,5 ,6 ]
Mayani, Hector [1 ,2 ,3 ,4 ,5 ,6 ]
机构
[1] IMSS, La Raza Med Ctr, Dept Pediat Hematol, Mexico City, DF, Mexico
[2] IMSS, Siglo XXI Med Ctr, Med Specialties Hosp, Dept Hematol, Puebla, Mexico
[3] IMSS, Siglo XXI Med Ctr, Pediat Hosp, Dept Hematol, Mexico City, DF, Mexico
[4] IMSS, Siglo XXI Med Ctr, Oncol Hosp, Oncol Res Unit, Mexico City, DF, Mexico
[5] IMSS, Gabriel Mancera Hosp, Dept Pediat, Mexico City, DF, Mexico
[6] IMSS, La Raza Med Ctr, Umbil Cord Blood Bank, Dept Pediat Hematol, Mexico City, DF, Mexico
关键词
D O I
10.1111/j.1537-2995.2007.01529.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Over the past decade, umbilical cord blood (UCB) banking and transplantation have increased significantly worldwide. The experience in developing countries, however, is still limited. In January 2005 the Mexican Institute of Social Security (IMSS) initiated its UCB banking and transplantation program. This study reports on the experience generated at this institution during the first 2 years of activities. STUDY DESIGN AND METHODS: A public UCB bank was established at La Raza Medical Center, IMSS, in Mexico City. Good manufacturing practices and standard operating procedures were used to address donor selection, as well as UCB collection, processing, and cryopreservation. Based mainly on human leukocyte antigen (HLA) and total nucleated cell (TNC) content, specific UCB units were thawed, processed, and released for transplantation. RESULTS: Based on stringent selection criteria, 360 UCB units were collected from January 2005 to December 2006. A total of 201 (56%) units (minimum volume, 50 mL without anticoagulant) were processed and stored. Median values for specific parameters were as follows: volume, 89.9 mL; viability, 94.8%; TNCs, 0.91 x 10(9); CD34+ cells, 3.13 x 10(6); and colony-forming cells, 1.20 x 10(6). During this period, 10 units had been released for transplantation to seven patients (six children and one adult). Engraftment was observed in five patients; four of them were still in remission (114-293 days after transplant). In spite of showing sustained engraftment, one patient died on Day +88. Two patients showed no engraftment and died 29 to 30 days after transplant. CONCLUSION: The results obtained during this initial period are encouraging and indicate that the UCB banking and transplantation program at IMSS will help to improve already existing hematopoietic cell transplant programs in Mexico. The experience generated at IMSS may be helpful to other institutions, particularly those in developing countries.
引用
收藏
页码:228 / 236
页数:9
相关论文
共 35 条
[1]   New trends in umbilical cord blood transplantation [J].
Ballen, KK .
BLOOD, 2005, 105 (10) :3786-3792
[2]   Creation of a double chimera after the transplantation of umbilical-cord blood from two partially matched unrelated donors [J].
Barker, JN ;
Weisdorf, DJ ;
Wagner, JE .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (24) :1870-1871
[3]   A modified cord blood collection method achieves sufficient cell levels for transplantation in most adult patients [J].
Bornstein, R ;
Flores, AI ;
Montalbán, MA ;
del Rey, MJ ;
de la Serna, J ;
Gilsanz, F .
STEM CELLS, 2005, 23 (03) :324-334
[4]   HUMAN UMBILICAL-CORD BLOOD AS A POTENTIAL SOURCE OF TRANSPLANTABLE HEMATOPOIETIC STEM PROGENITOR CELLS [J].
BROXMEYER, HE ;
DOUGLAS, GW ;
HANGOC, G ;
COOPER, S ;
BARD, J ;
ENGLISH, D ;
ARNY, M ;
THOMAS, L ;
BOYSE, EA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (10) :3828-3832
[5]   Expanding the role of umbilical cord blood transplantation [J].
Brunstein, Claudio G. ;
Setubal, Daniela C. ;
Wagner, John E. .
BRITISH JOURNAL OF HAEMATOLOGY, 2007, 137 (01) :20-35
[6]  
Chrysler G, 2004, CORD BLOOD BIOL IMMU, P219
[7]   Allogeneic hematopoietic stem cell transplantation from an alternative stem cell source in Fanconi anemia patients: analysis of 47 patients from a single institution [J].
de Medeiros, C. R. ;
Bitencourt, M. A. ;
Zanis-Neto, J. ;
Maluf, E. C. P. ;
Carvalho, D. S. ;
Bonfim, C. S. ;
Funke, V. M. ;
Setubal, D. C. ;
Farah, N. ;
Pasquini, R. .
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2006, 39 (10) :1297-1304
[8]   Growth kinetics of progenitor cell-enriched hematopoietic cell populations in long-term liquid cultures under continuous removal of mature cells [J].
Flores-Guzman, P. ;
Martinez-Jaramillo, G. ;
Montesinos, J. J. ;
Valencia, I. ;
Mayani, H. .
CYTOTHERAPY, 2006, 8 (03) :299-307
[9]   In vitro proliferation, expansion, and differentiation of a CD34+ cell-enriched hematopoietic cell population from human umbilical cord blood in response to recombinant cytokines [J].
Flores-Guzmán, P ;
Gutiérrez-Rodríguez, M ;
Mayani, H .
ARCHIVES OF MEDICAL RESEARCH, 2002, 33 (02) :107-114
[10]   HEMATOPOIETIC RECONSTITUTION IN A PATIENT WITH FANCONIS ANEMIA BY MEANS OF UMBILICAL-CORD BLOOD FROM AN HLA-IDENTICAL SIBLING [J].
GLUCKMAN, E ;
BROXMEYER, HE ;
AUERBACH, AD ;
FRIEDMAN, HS ;
DOUGLAS, GW ;
DEVERGIE, A ;
ESPEROU, H ;
THIERRY, D ;
SOCIE, G ;
LEHN, P ;
COOPER, S ;
ENGLISH, D ;
KURTZBERG, J ;
BARD, J ;
BOYSE, EA .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (17) :1174-1178